Introduction: The prevalence of type 2 diabetes (T2D) has increased dramatically in the last decades in developed and developing countries. In this regard, the purpose of this study is to investigate the prevalence of prediabetes and diabetes in retired athletes in Saudi Arabia and compare it to nonathletes. This study hypothesizes that early participation in sport can prevent former athletes from abnormal blood glucose levels after retirement. Methods: : The leading methods of researching the issues of the study include the analysis of theoretical sources, analysis of statistics, and comparison. Seventy-three former athletes and 26 nonathletes aged between 20 and 60 years participated in this study. Height, weight, and blood glucose levels were collected by the researcher. The former athletes were divided into 3 groups according to their type of training: endurance, mixed sports, and power sports. Results: The study results showed that 40.59% of former athletes had prediabetes compared to 16.83% of nonathletes. Furthermore, 8.91% of the former athletes had T2D, while 3.96% of the nonathletes had T2D. The results of this study indicated that former athletes had lower average blood glucose than nonathletes. Also, the study results indicated that no statistically significant differences were found between former athletes and nonathletes after retirement. About fasting blood glucose, former power athletes had higher average blood glucose than endurance athletes and mixed sports athletes. Conclusion: It was concluded that no statistically significant differences were found between the former athlete groups.

1.
World Health Organization
.
[Internet]. Global report on diabetes
.
WHO
;
2020
. [cited 2020 Apr 18]. Available from: https://apps.who.int/iris/handle/10665/204871.
2.
Aldossari
KK
,
Aldiab
A
,
Al-Zahrani
JM
,
Al-Ghamdi
SH
,
Abdelrazik
M
,
Batais
MA
,
Prevalence of prediabetes, diabetes, and its associated risk factors among males in Saudi Arabia: a population-based survey
.
J Diabetes Res
.
2018
;
2018
:
2194604
12
. .
3.
Laine
MK
,
Eriksson
JG
,
Kujala
UM
,
Wasenius
NS
,
Kaprio
J
,
Bäckmand
HM
,
A former career as a male elite athlete: does it protect against type 2 diabetes in later life?
Diabetologia
.
2014
;
57
(
2
):
270
4
. .
4.
Teramoto
M
,
Bungum
TJ
.
Mortality and longevity of elite athletes
.
J Sci Med Sport
.
2010
;
13
(
4
):
410
6
. .
5.
Batista
C
,
Soares
JM
.
Are former elite athletes more protected against metabolic syndrome?
J Cardiol
.
2013
;
61
(
6
):
440
5
. .
6.
Batista
CHX
,
Soares
JM
.
Is athletic background associated with a future lower prevalence of risk factors for chronic disease?
J Exerc Sci Fitness
.
2014
;
12
(
2
):
47
54
. .
7.
Emami
M
,
Behforouz
A
,
Jarahi
L
,
Zarifian
A
,
Rashidlamir
A
,
Rashed
MM
,
The risk of developing obesity, insulin resistance, and metabolic syndrome in former power-sports athletes ‒ does sports career termination increase the risk
.
Indian J Endocrinol Metab
.
2018
;
22
(
4
):
515
9
. .
8.
Sakung
JM
,
Sirajuddin
S
,
Zulkifli
A
,
Rahman
SA
,
Sudargo
T
.
Physical activity is associated with lower blood glucose level in high school teachers in Palu, Indonesia
.
Int J Community Med Public Health
.
2018
;
5
(
8
):
3176
. .
9.
Altowerqi
ZM
,
Zainuddin
ZAB
,
Hashim
AHBM
,
Almarwaey
AO
.
Are former athletes protected against obesity after retirement?
Indian J Public Health Res Dev
.
2020
;
11
(
02
):
1995
2000
.
10.
Altowerqi
ZM
,
Zainuddin
ZAB
,
Hashim
AHBM
,
Sayyd
SM
.
Metabolic syndrome and its components in former athletes: a review
.
Int J Psychos Rehabil
.
2020
;
24
(
06
):
8819
35
.
11.
World Health Organization
.
[Internet]. Classification of diabetes mellitus
.
WHO
;
2020
. [cited 2020 Apr 21]. Available from: https://www.who.int/publications/i/item/classification-of-diabetes-mellitus.
12.
Johansson
JK
,
Kujala
UM
,
Sarna
S
,
Karanko
H
,
Puukka
PJ
,
Jula
AM
.
Cardiovascular health in former elite male athletes
.
Scand J Med Sci Sports
.
2016
;
26
(
5
):
535
43
. .
13.
Melekoğlu
T
,
Sezgin
E
,
Işın
A
,
Türk
A
.
The effects of a physically active lifestyle on the health of former professional football players
.
Sports
.
2019
;
7
(
4
):
75
84
.
14.
Chang
AY
,
FitzGerald
SJ
,
Cannaday
J
,
Zhang
S
,
Patel
A
,
Palmer
MD
,
Cardiovascular risk factors and coronary atherosclerosis in retired national football league players
.
Am J Cardiol
.
2009
;
104
(
6
):
805
11
. .
15.
Miller
MA
,
Croft
LB
,
Belanger
AR
,
Romero-Corral
A
,
Somers
VK
,
Roberts
AJ
,
Prevalence of metabolic syndrome in retired national football league players
.
Am J Cardiol
.
2008
;
101
(
9
):
1281
4
. .
16.
Kujala
UM
,
Kaprio
J
,
Taimela
S
,
Sarna
S
.
Prevalence of diabetes, hypertension, and ischemic heart disease in former elite athletes
.
Metabolism
.
1994
;
43
(
10
):
1255
60
. .
17.
Kujala
UM
,
Sarna
S
,
Kaprio
J
.
Use of medications and dietary supplements in later years among male former top-level athletes
.
Arch Intern Med
.
2003
;
163
(
9
):
1064
8
. .
18.
Sarna
S
,
Kaprio
J
,
Kujala
UM
,
Koskenvuo
M
.
Health status of former elite athletes. The finish experience
.
Aging
.
1997
;
9
(
1-2
):
35
41
.
19.
Bäckmand
H
,
Kujala
U
,
Sarna
S
,
Kaprio
J
.
Former athletes’ health-related lifestyle behaviours and self-rated health in late adulthood
.
Int J Sports Med
.
2013
;
31
(
10
):
751
8
. .
20.
Chou
SW
,
Lai
CH
,
Hsu
TH
,
Cho
YM
,
Ho
HY
,
Lai
YC
,
Characteristics of glycemic control in elite power and endurance athletes
.
Prev Med
.
2005
;
40
(
5
):
564
9
. .
21.
Altowerqi
ZM
,
Abidin
Z
,
Sayyd
SM
,
Alkuhaili
WA
,
Alsayegh
MA
.
Dietary habits among former athletes in Saudi Arabia
.
Indian J Public Health Res Dev
.
2020
;
11
(
03
):
1069
74
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.